All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports
The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making
KCE Reports 324 (2019)
KCE Reports 306 (2019) A healthy lifestyle remains the most effective way of avoiding cardiovascular diseases and their consequences. Yet since 2002, the annual number of people who use cholesterol-lowering drugs from the statin family increased from 400,000 to 1,500,000. Currently, 25% of the population aged 40 and above take these drugs. Despite decreases in price due to the fact that all statins now exist in generic form, their total cost still stands at 160 million euros annually.